The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


TicoVac 0.5 ml Suspension for injection in a pre-filled syringeTick-Borne Encephalitis Vaccine (whole Virus, inactivated)



Pfizer Healthcare IrelandPA0822/184/001

Main Information

Trade NameTicoVac 0.5 ml Suspension for injection in a pre-filled syringeTick-Borne Encephalitis Vaccine (whole Virus, inactivated)
Active SubstancesTbe virus antigen
Dosage FormSuspension for injection in pre-filled syringe
Licence HolderPfizer Healthcare Ireland
Licence NumberPA0822/184/001

Group Information

ATC CodeJ07BA Encephalitis vaccines
J07BA01 encephalitis, tick borne, inactivated, whole virus

Status

License statusAuthorised
Licence Issued25/06/2004
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceBatches of human albumin used in manufacture shall be subject to control authority batch release in accordance with Article 114.2 of Directive 2001/83/EC as amended. Batches of finished product marketed in Ireland shall be subject to control authority batch release in accordance with Article 114.1 of Directive 2001/83/EC as amended.
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back